Pluristem and Korea’s CHA in $10.4m stem cell collaboration – Globes
|
Pluristem and Korea’s CHA in $10.4m stem cell collaboration
Globes Stem cell developer Pluristem Therapeutics Ltd. (Nasdaq:PSTI; DAX: PJT: PLTR) and Korea’s CHA Bio&Diostech (Kodaq: CHA) are pushing forward with the strategic partnership agreement reached in June. The two companies have concluded a mutual … Pluristem Therapeutics Inc. : Pluristem and CHA Move Forward on Strategic …4-traders (press release) |
